HNN3.0
Register
Register
Register

Project cooperationUpdated on 28 October 2026

Liquid-biopsy + AI biomarker of β-cell decline: partner for predictive biomarkers in diabetes or cardiometabolic disease (TOOL-01)

Professor, CEO/Founder at ABCureD

Alexandroupoli, Greece

About

ABCureD, the biomedical spin-off of Democritus University of Thrace (Greece), together with the university’s Laboratory of Pharmacology, is looking to join a consortium as the β-cell biomarker and liquid-biopsy partner.

Current diabetes biomarkers (HbA1c, glucose, C-peptide) show the consequences of β-cell failure. They don’t directly measure β-cell loss. Our patented LPancreas technology combines a cell-free DNA methylation signature of β-cell death with AI analysis. The result is a minimally invasive, direct readout of β-cell decline from a blood sample.

What we bring:

  • A patented biomarker (granted EP patent), with clinical data and validation to date

  • An established AI and bioinformatics pipeline, ready to adapt and integrate with other biomarkers, longitudinal data and real-world data

  • Laboratory capacity to analyse biobanked plasma from partner cohorts

  • Type 1 and type 2 diabetes cohorts in Greece, including paediatric sample collection

  • Clinical pharmacology expertise and an international diabetes research network

  • SME exploitation and commercialisation capacity

Track record: EIC Seal of Excellence; EP PerMed-funded project ; Pfizer Smart4Health award; Women TechEU Badge of Honour.

Looking for: a coordinator or consortium working on predictive biomarkers in type 2 diabetes, prediabetes, type 1 diabetes or cardiometabolic disease. We are especially interested in consortia with longitudinal cohorts or trials.

Role sought: Partner (work-package lead or task lead )

Topic

  • Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases

Organisation

ABCureD

Company (SME)

Alexandroupoli, Greece

Similar opportunities